Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.
Identifieur interne : 005187 ( Main/Exploration ); précédent : 005186; suivant : 005188Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.
Auteurs : Xuan Liu [République populaire de Chine] ; Yulin Shi ; Ping Li ; Linhai Li ; Yanping Yi ; Qingjun Ma ; Cheng CaoSource :
- Clinical and diagnostic laboratory immunology [ 1071-412X ] ; 2004.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- immunologie : Protéines nucléocapside, Syndrome respiratoire aigu sévère, Virus du SRAS.
- sang : Anticorps antiviraux.
- Adulte, Enfant, Facteurs temps, Humains, Test ELISA, Études cas-témoins.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Nucleocapsid Proteins.
- diagnosis : Severe Acute Respiratory Syndrome.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- Adult, Case-Control Studies, Child, Enzyme-Linked Immunosorbent Assay, Humans, Time Factors.
Abstract
Profiles of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in 445 probable SARS patients and 3,749 healthy people or non-SARS patients were analyzed by antigen-capturing enzyme-linked immunosorbent assay. Antinucleocapsid antibodies were elucidated in 17.5% of the probable SARS patients 1 to 7 days after the onset of symptoms and in 80% of the patients 8 to 14 days after the onset. About 90% of the probable SARS patients were positive 15 or more days after illness. Antibody titers increased up to 70 days, and high antibody titers were maintained at least for another 3 months. Of the healthy people and non-SARS patients, only seven (0.187%) were weakly positive.
DOI: 10.1128/cdli.11.1.227-228.2004
PubMed: 14715574
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003005
- to stream PubMed, to step Curation: 003005
- to stream PubMed, to step Checkpoint: 002B34
- to stream Ncbi, to step Merge: 000547
- to stream Ncbi, to step Curation: 000547
- to stream Ncbi, to step Checkpoint: 000547
- to stream Main, to step Merge: 005571
- to stream Main, to step Curation: 005187
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.</title>
<author><name sortKey="Liu, Xuan" sort="Liu, Xuan" uniqKey="Liu X" first="Xuan" last="Liu">Xuan Liu</name>
<affiliation wicri:level="1"><nlm:affiliation>Beijing Institute of Biotechnology, Beijing 100850, Peoples Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Institute of Biotechnology, Beijing 100850</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name>
</author>
<author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
</author>
<author><name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name>
</author>
<author><name sortKey="Yi, Yanping" sort="Yi, Yanping" uniqKey="Yi Y" first="Yanping" last="Yi">Yanping Yi</name>
</author>
<author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name>
</author>
<author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:14715574</idno>
<idno type="pmid">14715574</idno>
<idno type="doi">10.1128/cdli.11.1.227-228.2004</idno>
<idno type="wicri:Area/PubMed/Corpus">003005</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003005</idno>
<idno type="wicri:Area/PubMed/Curation">003005</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003005</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002B34</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002B34</idno>
<idno type="wicri:Area/Ncbi/Merge">000547</idno>
<idno type="wicri:Area/Ncbi/Curation">000547</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000547</idno>
<idno type="wicri:doubleKey">1071-412X:2004:Liu X:profile:of:antibodies</idno>
<idno type="wicri:Area/Main/Merge">005571</idno>
<idno type="wicri:Area/Main/Curation">005187</idno>
<idno type="wicri:Area/Main/Exploration">005187</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.</title>
<author><name sortKey="Liu, Xuan" sort="Liu, Xuan" uniqKey="Liu X" first="Xuan" last="Liu">Xuan Liu</name>
<affiliation wicri:level="1"><nlm:affiliation>Beijing Institute of Biotechnology, Beijing 100850, Peoples Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Institute of Biotechnology, Beijing 100850</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name>
</author>
<author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
</author>
<author><name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name>
</author>
<author><name sortKey="Yi, Yanping" sort="Yi, Yanping" uniqKey="Yi Y" first="Yanping" last="Yi">Yanping Yi</name>
</author>
<author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name>
</author>
<author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name>
</author>
</analytic>
<series><title level="j">Clinical and diagnostic laboratory immunology</title>
<idno type="ISSN">1071-412X</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antibodies, Viral (blood)</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Humans</term>
<term>Nucleocapsid Proteins (immunology)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Anticorps antiviraux (sang)</term>
<term>Enfant</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Protéines nucléocapside (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Test ELISA</term>
<term>Virus du SRAS (immunologie)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Protéines nucléocapside</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Humans</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Enfant</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Test ELISA</term>
<term>Études cas-témoins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Profiles of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in 445 probable SARS patients and 3,749 healthy people or non-SARS patients were analyzed by antigen-capturing enzyme-linked immunosorbent assay. Antinucleocapsid antibodies were elucidated in 17.5% of the probable SARS patients 1 to 7 days after the onset of symptoms and in 80% of the patients 8 to 14 days after the onset. About 90% of the probable SARS patients were positive 15 or more days after illness. Antibody titers increased up to 70 days, and high antibody titers were maintained at least for another 3 months. Of the healthy people and non-SARS patients, only seven (0.187%) were weakly positive.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name>
<name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name>
<name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
<name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name>
<name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name>
<name sortKey="Yi, Yanping" sort="Yi, Yanping" uniqKey="Yi Y" first="Yanping" last="Yi">Yanping Yi</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Liu, Xuan" sort="Liu, Xuan" uniqKey="Liu X" first="Xuan" last="Liu">Xuan Liu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005187 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005187 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:14715574 |texte= Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:14715574" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |